DS-5670a is a novel vaccine candidate for COVID-19, consisting of mRNA encapsulated in lipid nanoparticles (LNP-mRNA), which has been developed by Daiichi Sankyo Co., Ltd. (Tokyo, Japan) [7]. The lipid is a novel cationic compound; the mRNA encodes the receptor-binding domain (RBD) fr...